Amyloid deposition of α-synuclein (α-syn) is a hallmark of Parkinson’s disease (PD). α-Syn fibrillation and cell-to-cell transmission in the brain play an essential role in disease progression. To date, eight single-point mutations of SNCA have been identified in familial PD (fPD), which feature early-onset, severe and highly heterogeneous clinical symptoms.